Dorsey Wright & Associates Lantheus Holdings, Inc. Transaction History

Dorsey Wright & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$82.41 - $99.65 $2.17 Million - $2.62 Million	26,292 New	26,292 $2.21 Million
Q4 2019 Jan 31, 2020	SELL	$18.47 - $24.03 $8,717 - $11,342	-472 Closed	0 $0
Q2 2019 Jul 02, 2019	BUY	$23.33 - $28.3 $2,752 - $3,339	118 Added 33.33%	472 $13,000
Q1 2019 Apr 04, 2019	BUY	$14.93 - $25.1 $5,285 - $8,885	354 New	354 $9,000

533

73.2M

598K

371K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.19B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.